CTLA4 and neoplasm: Specifically, the immune checkpoints mediated by cytotoxic T-lymphocyte associated antigen-4 (CTLA-4), programmed cell death-1 (PD1), and programmed cell death ligand 1 (PD-L1) inhibit T-cell activation through their interaction with antigen-presenting cells or tumor cells [6].